Adrees M, Gibney J, El-Saeity N, Boran G
Department of Clinical Chemistry, Adelaide and Meath Hospital incorporating the National Children's Hospital, Dublin 24, Ireland.
Clin Endocrinol (Oxf). 2009 Aug;71(2):298-303. doi: 10.1111/j.1365-2265.2008.03509.x. Epub 2008 Dec 15.
Some of the cardiovascular and renal abnormalities seen in overt hypothyroidism have also been reported in subclinical hypothyroidism (SCH). Short-term L-T4 replacement in SCH improves cardiovascular risk markers and reduces carotid intima-media thickness (CIMT), a surrogate marker of atherosclerosis. The haemodynamic and renal effects of L-T4 replacement in SCH are poorly understood.
To compare cardiovascular risk factors and renal variables in women with SCH and normal women. To study the effects of L-T4 replacement in SCH subjects on these variables and on structural and functional changes in common carotid and brachial arteries.
Fifty-six women with SCH before and after L-T4 replacement for 18 months and 56 normal women of similar age distribution were studied. Blood Pressure (BP), plasma lipids and homocysteine were measured and renal function evaluated [estimation of glomerular filtration rate (eGFR) using standard equations and measurement of serum Cystatin-C] in women with SCH before and after 18 months of l-T4, and in healthy women. CIMT and endothelial function (using brachial artery ultrasound) were studied before and after L-T4 in a subgroup of women with SCH.
Systolic and diastolic BP, total cholesterol, triglyceride, LDL-cholesterol, lipoprotein(a) and homocysteine were greater in SCH (P < 0.05), and following L-T4 replacement decreased (P < 0.05) to levels that no longer differed from normal subjects. Estimated GFR was reduced and serum Cystatin-C increased (P < 0.05) in SCH. These variables also normalized following L-T4. Following L-T4 replacement the carotid artery baseline diameter increased by 7.1% and CIMT decreased by a mean value of 13%, while brachial artery diameter increased basally by 12.5% and following endothelium-dependent vasodilatation by 17.5% (P < 0.05). However, the increment following reactive hyperaemia did not differ before or following L-T4 replacement.
Normalization of cardiovascular risk factors following L-T4 replacement in SCH potentially explains reduced CIMT. Increased carotid and brachial artery diameters and normalized eGFR indicates a haemodynamic effect of L-T4 replacement, the importance of which requires further investigation.
在临床显性甲状腺功能减退中出现的一些心血管和肾脏异常在亚临床甲状腺功能减退(SCH)中也有报道。对SCH进行短期L-T4替代治疗可改善心血管风险标志物,并降低颈动脉内膜中层厚度(CIMT),这是动脉粥样硬化的一个替代标志物。L-T4替代治疗对SCH患者血流动力学和肾脏的影响尚不清楚。
比较SCH女性和正常女性的心血管危险因素及肾脏指标。研究对SCH患者进行L-T4替代治疗对这些指标以及颈总动脉和肱动脉结构与功能变化的影响。
对56例接受L-T4替代治疗18个月前后的SCH女性以及56例年龄分布相似的正常女性进行研究。测量了SCH女性在L-T4治疗18个月前后以及健康女性的血压(BP)、血脂和同型半胱氨酸水平,并评估了肾功能[使用标准方程估算肾小球滤过率(eGFR)并测量血清胱抑素C]。对一组SCH女性在L-T4治疗前后进行了CIMT和内皮功能(使用肱动脉超声)研究。
SCH患者的收缩压和舒张压、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、脂蛋白(a)和同型半胱氨酸水平更高(P<0.05),L-T4替代治疗后降低(P<0.05)至与正常受试者无差异的水平。SCH患者的估算肾小球滤过率降低,血清胱抑素C升高(P<0.05)。这些指标在L-T4治疗后也恢复正常。L-T4替代治疗后,颈动脉基线直径增加7.1%,CIMT平均降低13%,而肱动脉直径基线增加12.5%,内皮依赖性血管扩张后增加17.5%(P<0.05)。然而,反应性充血后的增加在L-T4替代治疗前后无差异。
SCH患者L-T4替代治疗后心血管危险因素恢复正常可能解释了CIMT的降低。颈动脉和肱动脉直径增加以及eGFR恢复正常表明L-T4替代治疗具有血流动力学效应,其重要性需要进一步研究。